Frazier Financial Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$685 Sell
32
-90
-74% -$1.87K ﹤0.01% 660
2025
Q4
$2.61K Buy
+122
New +$2.5K ﹤0.01% 531

Other funds holding MD

Frazier Financial Advisors's MD Position: Q1 2026 in Review

Frazier Financial Advisors reduced its Pediatrix Medical (MD) stake by 74% in Q1 2026, selling an estimated $1.87K and leaving 32 shares worth $685. The position accounts for ﹤0.01% of the portfolio, ranked #660.

Frazier Financial Advisors first reported a position in MD in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.61K in Q4 2025. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Frazier Financial Advisors held 32 shares of Pediatrix Medical worth $685 as of Q1 2026.
  • Frazier Financial Advisors sold 90 Pediatrix Medical shares in Q1 2026, an estimated $1.87K.
  • Pediatrix Medical made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q1 2026, its #660 holding.
  • Frazier Financial Advisors first reported a position in Pediatrix Medical in Q4 2025 and has held it in 2 quarters since.
  • Frazier Financial Advisors's Pediatrix Medical position peaked at $2.61K in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.